Levofloxacin Baxter (Levofloxacin Hemihydrate)

Levofloxacin is a fluoroquinolone antibiotic used intravenously to treat serious bacterial infections.

• Community‑acquired bacterial pneumonia: provides rapid bacterial clearance and clinical improvement in adult patients.
• Complicated urinary tract infections: eradicates uropathogens resistant to other agents, supporting resolution of infection.
• Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic organisms, aiding recovery after surgical or medical management.
• Skin and soft‑tissue infections: eliminates common Gram‑positive and Gram‑negative pathogens, facilitating healing.

• Levofloxacin hemihydrate inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to the ATP‑binding sites of these enzymes, it prevents DNA strand separation and transcription, leading to bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild gastrointestinal upset occurring in many patients.
• Diarrhea: loose stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Rash: mild skin erythema or itching.
• Elevated liver enzymes: mild, asymptomatic transaminase rise.

Serious or Rare Side Effects

• Tendon rupture: especially Achilles, may occur without warning.
• QT interval prolongation: can lead to cardiac arrhythmias.
• Severe hypersensitivity reactions: including Stevens‑Johnson syndrome.
• Clostridioides difficile infection: colitis following disruption of gut flora.
• Central nervous system effects: seizures or confusion in susceptible individuals.

Before using Levofloxacin, clinicians should consider several safety precautions.

• Renal impairment: adjust therapy and monitor renal function.
• Hepatic dysfunction: use with caution in patients with liver disease.
• History of tendon disorders: avoid in patients with prior tendonitis or rupture.
• Cardiac risk: assess QT prolongation risk, especially with other QT‑prolonging drugs.
• Pregnancy and lactation: use only if benefits outweigh potential risks.
• Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate administration by at least 2 hours.
• Warfarin: may increase INR and bleeding risk; monitor coagulation parameters closely.
• Cyclosporine: increased risk of nephrotoxicity; consider dose adjustment.

Moderate Interactions (Monitor Closely)

• NSAIDs (e.g., ibuprofen): may increase risk of CNS stimulation or seizures.
• Theophylline: levofloxacin can raise plasma theophylline levels; monitor for toxicity.
• Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia; monitor blood glucose.